Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
total saponins of radix clematidis
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
Total saponins of Radix clematidis (TSC) is a natural product extract derived from the roots and rhizomes of *Clematis* species, including *Clematis chinensis*, *Clematis hexapetala*, and *Clematis mandshurica*. It is the primary active fraction responsible for the anti-arthritic properties of the traditional Chinese medicine Wei-ling-xian. TSC is composed of various triterpenoid saponins, with clematichinenoside AR identified as a major active component. Research indicates that TSC exerts therapeutic effects in rheumatoid arthritis (RA) by inhibiting the excessive proliferation of fibroblast-like synoviocytes (FLS). This is achieved through the modulation of the lncRNA OIP5-AS1/miR-410-3p/Wnt7b signaling axis and the inhibition of the Wnt/beta-catenin signaling pathway. TSC also influences metabolic processes involving glycerophospholipids, sphingolipids, and arachidonic acid.
- Other names
- Total saponins of Clematidis Radix et RhizomaWei-ling-xian saponins
02
Targets
CCND1 (Cyclin D1)CTNNB1 (Beta-catenin)GSK3 (Glycogen synthase kinase 3 beta)MYC (MYC proto-oncogene protein)SFRP5 (Secreted frizzled-related protein 5)WNT7B (Wnt family member 7B (commonly referred to as Protein Wnt-7b))OIP5-AS1 (OIP5 antisense RNA 1)miR-410-3p (MicroRNA 410-3p)
Beyond the preview
Go deeper on total saponins of radix clematidis.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on total saponins of radix clematidis.